KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Cash from Investing Activities (2017 - 2025)

Historic Cash from Investing Activities for Twist Bioscience (TWST) over the last 9 years, with Q4 2025 value amounting to -$9.9 million.

  • Twist Bioscience's Cash from Investing Activities fell 54667.97% to -$9.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$33.2 million, marking a year-over-year decrease of 27800.96%. This contributed to the annual value of -$24.8 million for FY2025, which is 70631.72% down from last year.
  • As of Q4 2025, Twist Bioscience's Cash from Investing Activities stood at -$9.9 million, which was down 54667.97% from -$12.4 million recorded in Q3 2025.
  • In the past 5 years, Twist Bioscience's Cash from Investing Activities ranged from a high of $104.6 million in Q2 2021 and a low of -$226.6 million during Q4 2021
  • For the 5-year period, Twist Bioscience's Cash from Investing Activities averaged around -$900400.0, with its median value being -$1.4 million (2024).
  • In the last 5 years, Twist Bioscience's Cash from Investing Activities skyrocketed by 40961.34% in 2023 and then plummeted by 122165.96% in 2025.
  • Over the past 5 years, Twist Bioscience's Cash from Investing Activities (Quarter) stood at -$226.6 million in 2021, then soared by 96.92% to -$7.0 million in 2022, then skyrocketed by 159.75% to $4.2 million in 2023, then plummeted by 136.88% to -$1.5 million in 2024, then tumbled by 546.68% to -$9.9 million in 2025.
  • Its last three reported values are -$9.9 million in Q4 2025, -$12.4 million for Q3 2025, and -$9.4 million during Q2 2025.